WE are getting ahead of ourselves here. The company is simply expanding manufacturing capacity to cover "POTENTIAL" commercial use AND (IMO at this stage, mainly for) further registered trials. It makes sense if we are not seeing adverse effects we expand production for trial use (or further while at it to save cost, going by a calculated RISK) but it would be jumping ahead of ourselves to think we are shaping up as a production company.
Once again, for me, positive trial data is all i can ask for and i am not at all concerned how and who produces it at this point in time.
WE are getting ahead of ourselves here. The company is simply...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
0.003(0.77%) |
Mkt cap ! $475.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $346.5K | 1.068M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 148237 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 274283 | 29 |
View Market Depth
| Last trade - 13.43pm 01/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |